Teressa Weaver (asker) May 25, 2013:

Billh, please just post your own solution. Right now there is only one suggestion solution for me to select.

Helena Chavarria May 25, 2013:

@Bill I only know what I know (which, unfortunately, is next to nothing). I am only trying to be helpful and if you have a better suggestion, with references, I'm sure everyone would appreciate it. I post my answers because I enjoy helping peers and I love learning, not because I feel like entering into an argument.

Billh May 25, 2013:

I don't object to marketing but Jun 12, 2008 – This is not a full marketing authorization, but, as its name suggests, has conditions attached. ... to the EMEA for an accelerated or exceptional authorization. ... It is designed to provide the public with access to medicines where

[PDF]
Practical Guidance for Conducting a Review - World Health ...
www.who.int/medicines/areas/quality_safety/.../GuideAssessR...‎
... Drugs and Traditional. Medicines, World Health Organization, Geneva, Switzerland. .... Post Marketing surveillance and controls - Module 9 . ...... exceptional authorization, conditional authorization, treatment programmes) should also be ...

Substandard medicines in resource-poor settings: a problem that ...
onlinelibrary.wiley.com/doi/10.1111/j.1365-3156.2008.02106.x/pdf
by JM Caudron - 2008 - Cited by 77 - Related articles
The circulation of substandard medicines in the developing world is a serious clinical and public health concern. ... for the domestic market (European Commission Human- itarian Aid ..... be accepted, a temporary exceptional authorization to ...

[PDF]
The Journal of Workers Compensation - Broadspire
www.choosebroadspire.com/PDFs/JWC_2008Fall_Lazarovic.pdf‎
mulary drug may tr

Teressa Weaver (asker) May 25, 2013:

The citation provided by Chavarria calls it "exceptional circumstances"

Billh May 25, 2013:

I think this is an exceptional authorisation, NOT exceptional commercialisation.